Penumbra, Inc. (PEN)
330.07
+0.20
(+0.06%)
USD |
NYSE |
Apr 07, 16:00
330.07
0.00 (0.00%)
After-Hours: 16:14
Penumbra EPS Diluted (Quarterly) : 1.202 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Intuitive Surgical, Inc. | 2.205 |
| Revvity, Inc. | 0.8708 |
| Globus Medical, Inc. | 1.029 |
| Abbott Laboratories | 1.030 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 47.34M |
| Revenue (Quarterly) | 385.38M |
| Total Expenses (Quarterly) | 338.04M |
| Enterprise Value | 12.62B |
| Gross Profit Margin (Quarterly) | 66.88% |
| Profit Margin (Quarterly) | 12.28% |
| Earnings Yield | 1.37% |
| Operating Earnings Yield | 1.46% |
| Normalized Earnings Yield | 1.373 |